Eosinophil: A Nonnegligible Predictor in COVID-19 Re-Positive Patients
Xiaolu Li(Children's Hospital of Chongqing Medical University), Tao Yu(Shanghai Jiao Tong University), Deqing Yin, Xiuxiu Fu(Qingdao University), Shengxiang Ji, Yanyan Yang(Wannan Medical College), Zhibin Wang(Qingdao University), Chunhua Bi(Qingdao University), Fachun Jiang(Qingdao Municipal Center for Disease Control and Prevention), Guangren Ma
Cited by 14
Related Papers
Lactate metabolism in human health and disease
|Signal Transduction and Targeted Therapy|2022|1.4k
Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China
|SSRN Electronic Journal|2020|963
CRISPR/Cas9 therapeutics: progress and prospects
|Signal Transduction and Targeted Therapy|2023|706
Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19
|The Science of The Total Environment|2020|158
Role of acetylation in doxorubicin-induced cardiotoxicity
|Redox Biology|2021|139